Please use this identifier to cite or link to this item:
Title: The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecules
Author: de la Torre, Beatriz G.
Albericio Palomera, Fernando
Keywords: Disseny de medicaments
Drug design
Issue Date: 27-Feb-2017
Publisher: MDPI
Abstract: This is an analysis from a chemical point of view of the 22 drugs accepted by the FDA during 2016. The different drugs from the 2016 "harvest" have been classified according to their chemical structure: antibodies; TIDES (oligonucleotides and peptides); amino acids and natural products; drug combination; and small molecules.
Note: Reproducció del document publicat a:
It is part of: Molecules, 2017, vol. 22, num. 3, p. 368
Related resource:
ISSN: 1420-3049
Appears in Collections:Articles publicats en revistes (Química Inorgànica i Orgànica)

Files in This Item:
File Description SizeFormat 
681089.pdf1.45 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons